SKYE BIOSCIENCE INC. - COMMON STOCK

Skye Bioscience to Participate in Upcoming Healthcare Investment Conferences

26 أغسطس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

23 أغسطس 2024 17:45:36 بحسب Nasdaq GlobeNewswire

Skye Bioscience Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacimab, in Patients with Obesity

22 أغسطس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience Reports Second Quarter 2024 Financial Results and Recent Highlights

09 أغسطس 2024 16:59:37 بحسب Nasdaq GlobeNewswire

Skye Bioscience Hosts Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” and Details Phase 2 Nimacimab Clinical Trial Design Including Obstructive Sleep Apnea Exploratory Endpoints

24 يوليو 2024 05:00:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience to Host Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” on July 24th

11 يوليو 2024 06:15:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience Establishes Metabolic Clinical and Scientific Advisory Board to Support Development of Nimacimab

11 يوليو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience Appoints Dr. Karen Smith to Board of Directors

03 يوليو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience Added to Russell 2000® and Russell 3000® Indexes

01 يوليو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Skye BioScience Participating in Piper Sandler Virtual Obesity Day

25 يونيو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Skye Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program

10 يونيو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience to Present at Jefferies Global Healthcare Conference

03 يونيو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting

10 مايو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting

30 أبريل 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience to Present at Upcoming Investment Conferences

23 أبريل 2024 06:00:00 بحسب Nasdaq GlobeNewswire